Hitting cancer with high-intensity ultrasound, immunotherapy
In a new study, researchers have shown that combining high-intensity focused ultrasound with two immunotherapies (a PD-1 checkpoint inhibitor and TLR9 agonist) can produce excellent response rates in mouse models of epithelial cancer. They also found that, for the combination to be effective, immunotherapies must come first.
Source: ScienceDaily Headlines - Category: Science Source Type: news
More News: Cancer | Cancer & Oncology | Epithelial Cancer | High Intensity Focused Ultrasound Therapy | Immunotherapy | Science | Study | Ultrasound